UK embryo agency faces the axe
By Daniel Cressey,
Nature
| 08. 03. 2010
In the ethically fraught field of human-embryo research, Britain's
Human Fertilisation and Embryology Authority (HFEA) has long been regarded as a world leader in regulating and advising scientists.
But now the HFEA faces the axe, and researchers and politicians are chorusing their discontent. "I'm absolutely astonished at this," says Ruth Deech, an independent member of the House of Lords and former chair of the HFEA. "I think our standing in the world will be reduced."
Since it was created by the Human Fertilisation and Embryology Act in 1990, the HFEA has regulated fertility treatment and research involving human embryos in the United Kingdom (see '
The development of an embryo agency'). Its work involves inspecting and licensing centres, as well as providing ethical and legal advice to scientists and the public. Scientists have generally applauded the HFEA for providing a clear set of boundaries for what research is permissible. "It's looked upon as an organization that is often the first to make decisions that define scientific and clinical barriers," says Justin St. John, director of the Centre for Reproduction...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By Sarah A. Topol, The New York Times Magazine | 12.14.2025
The women in House 3 rarely had a chance to speak to the women in House 5, but when they did, the things they heard scared them. They didn’t actually know where House 5 was, only that it was huge...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...